SMLR Latest Report

Semler Scientific's Financial Performance

Based on the provided data, Semler Scientific's total operating revenue in 2024 was RMB124.13 million, a decrease of approximately 17.5% from RMB150.57 million in 2023, indicating a decline in total operating revenue year-on-year. This change suggests that the company's revenue performance in the past year was not as good as the previous year, possibly reflecting changes in market demand, competition, or the company's operating strategy.

Key Financial Data

1. Semler Scientific's cumulative revenue in the first three quarters of the 2024 fiscal year was US$43.8810 million, a decrease of 17.40% year-on-year, indicating market pressure faced by the company.

2. Net profit decreased by 28.54%, reflecting a significant impact on the company's profitability in the face of declining revenue.

3. Reduced demand for Semler Scientific's products and intensified industry competition were the main reasons for the revenue decline.

4. Despite progress in the promotion of new products, overall operating revenue was still suppressed by the market environment.

Peer Comparison

1. Industry-wide analysis: The overall market demand for medical devices is expected to decline 2.4% in 2024, mainly due to the medical industry's rectification and restrictions on high-priced low-value consumables, which may be the industry context for Semler Scientific's revenue decline. [Source](http://ai.iwencai.com/searchapp/content.html#type=report_pdf&uid=f60293e2037243f0)

2. Peer evaluation analysis: Compared with other companies in the same industry, Semler Scientific's total operating revenue decreased significantly, indicating that its market share may be squeezed. Among its competitors, Titan Technology also experienced a significant decline in net profit in the first half of 2024, showing the intense competition and profit pressure in the industry.

Summary

In summary, Semler Scientific's operating revenue and net profit in 2024 both declined significantly, mainly due to weak market demand, intensified competition, and increased investment in research and development. Although the company has progressed in the promotion of new products, it was unable to effectively offset the overall decline in operating revenue.

Opportunities

1. With the growth of high-value consumables, Semler Scientific can consider strengthening its product development and market promotion in this area.

2. The company can attract more customers and increase sales revenue by optimizing its product pricing strategy.

3. By strengthening cooperation with medical institutions, the company can enhance the market penetration rate of its products and increase operating revenue.

Risks

1. Intensified competition in the industry may cause Semler Scientific to further lose market share, affecting its future revenue performance.

2. Uncertainty in the macroeconomic environment may continue to suppress consumer spending, affecting the company's sales.

3. The promotion effect of new products may not be significant, leading to the company's inability to improve operating revenue in the short term.